| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.6 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.7 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.7 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |